Family Office Of America (FOFA) Cash from Investing Activities (2026)
Family Office Of America (FOFA) reported Cash from Investing Activities of -$38285.0 for Q1 2026.
Family Office Of America (FOFA) Cash from Investing Activities (2026) Analysis & Trends
Family Office Of America (FOFA) has 1 years of Cash from Investing Activities data on file, last reported at -$38285.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | -38,285.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,285.00 |
| Mar 31, 2026 | -38,285.00 |